Navigation Links
Cardinal Health Names Carrie Cox to Board of Directors

DUBLIN, Ohio, Dec. 2 /PRNewswire-FirstCall/ -- Cardinal Health today announced that Carrie Cox will serve on the company's board of directors, effective immediately.

Cox, 52, most recently served as executive vice president and president of global pharmaceuticals at Schering-Plough Corp. She completed her tenure with the company at the close of its merger with Merck last month.

Prior to her term at Schering-Plough, Cox served as president of Pharmacia Corp.'s global pharmaceutical business. She had joined Pharmacia's predecessor company, Pharmacia & Upjohn, in 1997 and held a number of positions of increasing responsibility there.

"Carrie brings an extraordinary range of experiences from her 30 years in biopharmaceuticals and health care," said George S. Barrett, chairman and chief executive officer of Cardinal Health. "We are very excited to be able to draw on her perspectives and insights as we continue to execute on our strategic vision."

Cox has received numerous industry awards, and FORTUNE magazine named her to its list of the "50 Most Powerful Women in Business" on six separate occasions, including five consecutive years since 2005. She is a member of the board of directors of Texas Instruments, a member of the Health Policy and Management Executive Council at the Harvard School of Public Health and a member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology.

Cox received a Bachelor of Science degree from the Massachusetts College of Pharmacy in 1981.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a Fortune 18 health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability. As one of the largest health care companies in the world, Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 40,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at

SOURCE Cardinal Health, Inc.

SOURCE Cardinal Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AmeriCares Honors Cardinal Health with Power of Partnership Award
2. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
3. Cardinal Health Completes Enturia Acquisition
4. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
5. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
6. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
7. RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation
8. Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems
9. WebMD Announces 2009 Health Heroes
10. Covance to Present at Piper Jaffray 21st Annual Health Care Conference
11. Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims
Post Your Comments:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):